Institute of Cardiovascular Sciences We are leaders in cardiovascular research, including atrial fibrillation and heart failure, thrombosis and haemostasis, and vascular biology.
News Study outlines mechanism behind rare blood clots linked to COVID-19 vaccine New research carried out in collaboration with the University of Birmingham has characterised a rare COVID-19 vaccine-induced syndrome which causes blood clots.
News New research award to investigate and treat thrombo-inflammation in diseases where red blood cell destruction occurs
News Clinical trial led by Bimingham Professor shows digoxin is effective for treatment of atrial fibrillation
Posted 06 May 2021 University of Birmingham joins drug discovery collaboration with Evotec and Bristol Myers Squibb The University of Birmingham is part of a new industry collaboration launched to accelerate drug discovery projects that will fast track research from lab to patient.
Posted 23 April 2021 Study outlines mechanism behind rare blood clots linked to COVID-19 vaccine New research carried out in collaboration with the University of Birmingham has characterised a rare COVID-19 vaccine-induced syndrome which causes blood clots.
Posted 21 April 2021 Birmingham Health Innovation Campus takes another step forward after planning permission granted Work is set to begin on the first phase of Birmingham Health Innovation Campus this Summer after planning permission was granted by Birmingham City Council.
Posted 14 April 2021 New research award to investigate and treat thrombo-inflammation in diseases where red blood cell destruction occurs Dr Julie Rayes has been awarded a highly regarded Intermediate Fellowship to better understand and to test and repurpose drugs to limit thrombo-inflammation when it is caused by infection or congenital disorders.